Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that all-too-familiar routine of meetings, deadlines, and what-not has predictably returned. Getting started may be still more difficult today, thanks to a dollop of snow drops, which are blanketing the Pharmalot campus. Just when you thought spring had finally sprung, yes? Well, this calls for a few cups of stimulation as we juggle our laptop and our shovel. Meanwhile, here are some tidbits. Have a terrific day and do keep in touch …

Takeda (TAK) Pharmaceutical (TKPYY) is facing questions over its ability to finance a debt-fueled deal for Shire (SHPG) without placing further strain on its stretched finances, The Telegraph tells us. Moody’s Investor Service has warned that Takeda will need to pile more debt onto its already weakened balance sheet if it wants to buy the drug maker. Shire has expanded through a series of acquisitions that have seen its annual revenues rise to more than $15 billion, but have also left it shouldering a $27 billion debt load.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • May I observe that the continued snowy weather conditions in the Northeast US are becoming tiresome, although the observation itself is indeed becoming “tiresome.” (With no reference to shoveling activities … exercise is good for one, is it not?)

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy